The Biomanufacturing Fund (BMF) will provide up to £38 million in capital grants to incentivise investment in the manufacture of vaccines and biotherapeutics, to improve the UK’s health resilience for future pandemics.
The BMF follows on from the £60 million Life Sciences Innovative Manufacturing Fund and the £20 million Medicines and Diagnostics Manufacturing Transformation Fund.
We particularly welcome applications for the manufacture of:
for the following product categories:
This list is not exhaustive.
This is a summary of the minimum requirements for ‘in scope’ projects (read the scheme guidance for full details).
Your manufacturing investment must relate to the manufacture of:
Human medicines (this includes both the manufacture of active pharmaceutical ingredients (API) / drug substance and finished product / drug product). The fund is open to applications across the breadth of types of MHRA licenced medicines for human use.
We will not accept applications that propose to manufacture:
Your project must:
You will be required to:
To protect public funding, you must:
We will prioritise applicants based on their alignment to the fund’s objectives:
1. Increasing health resilience in the UK for future pandemics through increased domestic capacity, or by providing flexible capabilities that have the ability to be re-deployed;
2. Creating economic opportunity through investments that will make a substantial contribution to Gross Value Added and provide high-wage, high-skilled jobs.
1. If your company and project meet ALL the criteria listed above and you confirm you will be able to provide the required evidence and financial guarantees - submit a short summary of your project (no longer than one side of A4) outlining:
Send the summary to the BMF project team at email@example.com. We recommend you share this with the BMF project team well in advance of the EOI deadline (step 2) so we have adequate time to discuss your application with you. This summary will enable the BMF team to advise on whether your project is likely to be in scope and your company is eligible to apply. It will not be used to assess the merits of the project; if your project is eligible, it will be assessed subsequently as part of the Expression of Interest phase and interview.
2. Subject to the conversation you have had with the BMF Project Team, you should complete an Expression of Interest (EOI) form. These will be reviewed as described below:
We aim to open the fund in 2 phases, with the following deadlines to submit EOIs:
Phase 1 deadlines for EOIs:
If funding remains available at the end of Phase 1, we will re-open the fund for a Phase 2. The below dates are indicative.
Phase 2 deadlines for EOIs:
We encourage you to apply early as the fund will close once all funding is allocated.
Applicants who apply in the 1st phase (June-July 2023) will be prioritised for due diligence, especially if they will spend a substantial amount of the grant before March 2024.
3. Applicants will be invited for an online interview approximately 2 weeks after the EOI deadline. We will inform you of your slot the previous week.
4. Applicants will be informed whether they have been successful at the EOI stage approximately one month after the EOI deadline. If successful, you will be invited to submit a full application. We will organise a briefing call to help you understand how you should complete the full application form and to agree a date for when you should submit your application by.
Projects that have applied to the Life Sciences Innovative Manufacturing Fund (LSIMF) are welcome to apply to BMF, as long as they meet the criteria and eligibility requirements. Projects will only be able to receive funding from one of these; applications can only be considered for one fund.
If you have already submitted an Expression of Interest to the LSIMF Phase 2 that opened on 2 May 2023 and you think your project might be better suited for BMF, please contact the BMF support team.
Contact the BMF support team if you have any queries about the fund: firstname.lastname@example.org.
Find out more here: Biomanufacturing Fund (BMF): open to expressions of interest - GOV.UK (www.gov.uk)